Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)

CAPS Rating: 1 out of 5

The Company's mission is to discover, develop, and deliver to patients medicines for the treatment of cancer and related conditions.

Recs

0
Player Avatar cardiacarrest (20.82) Submitted: 1/12/2007 10:32:50 AM : Outperform Start Price: $14.10 INFI Score: -8.39

Yes the madly ambitious Julian Adams at least has a track record to back up his new venture in Infinity. He and his sharp CEO have gone from basically nothing to on the market and in the clinic in 3 years. It should keep charging along....

Featured Broker Partners


Advertisement